| Long name | APOA2 Primary Polyclonal Antibody |
| Also known as | APOA2 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | APOA2 |
| Specificity | This is a highly specific antibody against APOA2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 25-75/100 |
| Subcellular location | Secreted |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human APOA2 |
| Gene ID number | 336 |
| Swiss Prot | P02652 |
| Tested Applications | IF(IHC-P), IHC-P |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA, The apolipoprotein A II gene consists of 4 exons and 3 introns, The four exons encode the 5' untranslated region, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices, pre peptide, Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2, apoAII |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | APOA2 |
| Short name | APOA2 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | apolipoprotein A-II (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | APOA2 and IDBG-104234 and ENSG00000158874 and 336, APOA2 and IDBG-630130 and ENSBTAG00000009212 and 505394, Apo-AII and ApoA-II and apoAII, Apoa2 and IDBG-204212 and ENSMUSG00000005681 and 11807, Extracellular, high-density lipoprotein particle receptor binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0002740 and negative regulation of cytokine secretion involved in immune response and biological process this GO :0005319 and lipid transporter activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005829 and cytosol and cellular component this GO :0006457 and protein folding and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006656 and phosphatidylcholine biosynthetic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0005319: lipid transporter activity, this GO :0005319: lipid transporter activity and also this GO :0005515: protein binding and also this GO :0005543: phospholipid binding and also this GO :0008035: high-density lipoprotein particle binding and also this GO :0008289: lipid binding and also this GO :0015485: cholesterol binding and also this GO :0017127: cholesterol transporter activity and also this GO :0031210: phosphatidylcholine binding and also this GO :0034190: apolipoprotein receptor binding and also this GO :0042803: protein homodimerization activity and also this GO :0046982: protein heterodimerization activity and also this GO :0055102: lipase inhibitor activity and also this GO :0060228: phosphatidylcholine-sterol O-acyltransferase activator activity and also this GO :0070653: high-density lipoprotein particle receptor binding, this GO :0005515: protein binding, this GO :0005543: phospholipid binding, this GO :0008035: high-density lipoprotein particle binding, this GO :0008289: lipid binding, this GO :0015485: cholesterol binding, this GO :0017127: cholesterol transporter activity, this GO :0031210: phosphatidylcholine binding, this GO :0034190: apolipoprotein receptor binding, this GO :0042803: protein homodimerization activity, this GO :0046982: protein heterodimerization activity, this GO :0055102: lipase inhibitor activity, this GO :0060228: phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0070653: high-density lipoprotein particle receptor binding, visible light and biological process this GO :0008035 and high-density lipoprotein particle binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0009395 and phospholipid catabolic process and biological process this GO :0009749 and response to glucose and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010903 and negative regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0016032 and viral process and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0018158 and protein oxidation and biological process this GO :0018206 and peptidyl-methionine modification and biological process this GO :0030300 and regulation of intestinal cholesterol absorption and biological process this GO :0030301 and cholesterol transport and biological process this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031647 and regulation of protein stability and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034380 and high-density lipoprotein particle assembly and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042493 and response to drug and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043627 and response to estrogen and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045416 and positive regulation of interleukin-8 biosynthetic process and biological process this GO :0046340 and diacylglycerol catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051384 and response to glucocorticoid and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060192 and negative regulation of lipase activity and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0060621 and negative regulation of cholesterol import and biological process this GO :0060695 and negative regulation of cholesterol transporter activity and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070653 and high-density lipoprotein particle receptor binding and molecular function this GO :0072562 and blood microparticle and cellular component, apolipoprotein A-II |
| Identity | 601 |
| Gene | APOA2 |
| Long gene name | apolipoprotein A2 |
| Synonyms gene name | apolipoprotein A-II |
| Locus | 1q23, 3 |
| Discovery year | 2001-06-22 |
| Entrez gene record | 336 |
| Pubmed identfication | 2415515 |
| RefSeq identity | NM_001643 |
| Classification | Apolipoproteins |
| Havana BLAST/BLAT | OTTHUMG00000034346 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue